Table 2.
Correlation of normalised viral concentration/viral load to epidemiological outcomes (7-day rolling average) for the entire study period (weeks 23–44) and the rising phase of the second wave (weeks 23–40).
| Weighted average |
Viral load |
|||
|---|---|---|---|---|
| Same week r2 |
Next week r2 | Same week r2 |
Next week r2 | |
| 23–44 weeks | ||||
| Active cases | 0,421⁎⁎ | 0,462⁎⁎⁎ | 0,555⁎⁎⁎ | 0,589⁎⁎⁎ |
| Daily new cases | 0,575⁎⁎⁎ | 0,433⁎⁎⁎ | 0,670⁎⁎⁎ | 0,522⁎⁎⁎ |
| Hospitalised cases | 0,242⁎ | 0,250⁎ | 0,351⁎⁎ | 0,363⁎⁎ |
| Deaths | 0,076 | 0,119 | 0,187⁎ | 0,235⁎ |
| 23–40 weeks | ||||
| Active cases | 0,514⁎⁎⁎ | 0,645⁎⁎⁎ | 0,589⁎⁎⁎ | 0,697⁎⁎⁎ |
| Daily new cases | 0,720⁎⁎⁎ | 0,693⁎⁎⁎ | 0,716⁎⁎⁎ | 0,665⁎⁎⁎ |
| Hospitalised cases | 0,222 | 0,347⁎ | 0,278⁎ | 0,397⁎⁎ |
| Deaths | 0,145 | 0,560⁎ | 0,246 | 0,653⁎ |
p < 0.05.
p < 0.01.
p < 0.001.